雜志介紹

Clinical Cosmetic And Investigational Dermatology雜志介紹

《Clinical Cosmetic And Investigational Dermatology》是一本以English為主的開放獲取國際優秀期刊，中文名稱臨床化妝品和研究性皮膚病學，本刊主要出版、報道醫學-DERMATOLOGY領域的研究動態以及在該領域取得的各方面的經驗和科研成果，介紹該領域有關本專業的最新進展，探討行業發展的思路和方法，以促進學術信息交流，提高行業發展。該刊已被國際權威數據庫SCIE收錄，為該領域相關學科的發展起到了良好的推動作用，也得到了本專業人員的廣泛認可。該刊最新影響因子為1.9，最新CiteScore 指數為2.8。

本刊近期中國學者發表的論文主要有：

• Single-Cell RNA Sequencing Reveals Cellular Heterogeneity in an Acral Amelanotic Melanoma After Immunotherapy Treatment

  Author: Zhuang, Le; Tian, Jie; Lai, Binbin; Zhang, Guohong; Li, Hang

• Autophagy Inhibits Inflammation via Down-Regulation of p38 MAPK/mTOR Signaling Cascade in Endothelial Cells

  Author: Zhou, Ling; Wang, Juanjuan; Hou, Hui; Li, Jiao; Li, Juan; Liang, Jiannan; Li, Junqin; Niu, Xuping; Hou, Ruixia; Zhang, Kaiming

• A Giant Mixed Infiltrative Angiolipoma of the Back with Venous Malformation- A Case Report and Related Gene Mutation Detection

  Author: Zhao, Fangning; Yang, Zhenyu; Yang, Xiaonan

• Perinevoid Alopecia: Report of Two Cases and Literature Review

  Author: Zhang, Yujing; Zhang, Jianzhong; Zhou, Cheng

英文介紹

Clinical Cosmetic And Investigational Dermatology雜志英文介紹

Clinical, Cosmetic and Investigational Dermatology is an international, peer-reviewed, open access journal that focuses on the latest clinical and experimental research in all aspects of skin disease and cosmetic interventions. Normal and pathological processes in skin development and aging, their modification and treatment, as well as basic research into histology of dermal and dermal structures that provide clinical insights and potential treatment options are key topics for the journal.

Patient satisfaction, preference, quality of life, compliance, persistence and their role in developing new management options to optimize outcomes for target conditions constitute major areas of interest.

The journal is characterized by the rapid reporting of clinical studies, reviews and original research in skin research and skin care.

All areas of dermatology will be covered; contributions will be welcomed from all clinicians and basic science researchers globally.